Publicado
In situ tracking ion-exchange during Li+/Na+/K+ substitution: Bipolar disorder treatment through drug delivery system
Seguimiento in situ del intercambio iónico durante la sustitución de Li+/Na+/K+: Tratamiento del trastorno bipolar mediante un sistema de administración de fármacos
Rastreamento in situ da troca iônica durante a substituição de Li+/Na+/K+: Tratamento do transtorno bipolar por meio de sistemas de liberação de fármacos
DOI:
https://doi.org/10.15446/rcciquifa.v55n2.126491Palabras clave:
Cell membrane, ion transport, Li+Na+ & Li+K+, Si-based nanostructure, DFT (en)Membrana celular, transporte iónico, Li+Na+ y Li+K+, nanoestructura basada en Si, DFT (es)
Membrana celular, transporte iônico, Li+Na+ e Li+K+, nanoestrutura à base de Si, DFT (pt)
Descargas
Introduction: Bipolar disorder (BD) is considered one of the most dangerous diseases in developed countries. Despite scientific efforts, BD remains a significant concern due to its wide range of side effects. Various drugs based on lithium salts have been instrumental in treating patients with this disorder. However, the main issue with lithium salts is their known toxic effects, which can vary depending on the dose, route, and duration of administration. It is important to also consider the anionic component of lithium salts in any treatment plan. Research into novel algorithms for rare events has led to improvements in force-field parameters and an increase in the understanding of lipid membrane protein transmembrane. These advancements have allowed for the simulation of a comprehensive model of lithium-ion diffusion into channels. Additionally, Ge, Sn/Si-nanoparticles have been utilized as excipients in pharmaceutical nano biotechnology. More recently, silicon/germanium oxide has been developed for use in drug delivery systems. Methodology: A comprehensive investigation on Li+Na+(SiOGe), Li+K+(SiOGe), Li+Na+(SiOSn), and Li+K+(SiOSn) was accomplished by the "CAM–B3LYP–D3/6-311+G (d,p)" level of DFT theory. The hypothesis of the ions transporting was corroborated through density distributions of CDD, TDOS, and ESP for nanoclusters of Li+Na+(SiOGe), Li+K+(SiOGe), Li+Na+(SiOSn), and Li+K+(SiOSn). Results: This ion transport produces an electrochemical gradient that is crucial for several cellular activities, such as cell volume regulation, electrical excitability, and secondary active transport. Properties of GSK-3 as a specific function for BD drug design came out from data researches, which are important to several of central processes, such as glycogen synthesis and gene therapy. Through docking with 6tcu, the amounts of the Gemdock have sequenced as Li+K+(SiOGe)> Li+Na+(SiOGe)> Li+K+(SiOSn)> Li+Na+(SiOSn), indicates the instability of these complexes by GSK3b folded monomer. In other words, instability in cytoplasm solution means stability in complexes structures or due to the heteroclusters properties. These perfect and accurate structures from ion channels have largely modified for improving our understanding of the molecular details and ion selectivity and conduction. The current study aims to explore various aspects, including describing the atomic detail structure, molecular and functional properties, and consequently, its incomplete action due to structural alterations.
Introducción: El trastorno bipolar (TB) se considera una de las enfermedades más peligrosas en los países desarrollados. A pesar de los esfuerzos científicos, el TB sigue siendo una preocupación importante debido a su amplia gama de efectos secundarios. Diversos fármacos basados en sales de litio han sido fundamentales en el tratamiento de pacientes con este trastorno. Sin embargo, el principal problema con las sales de litio son sus conocidos efectos tóxicos, que pueden variar según la dosis, la vía de administración y la duración de la misma. Es importante considerar también el componente aniónico de las sales de litio en cualquier plan de tratamiento. La investigación de nuevos algoritmos para eventos raros ha permitido mejorar los parámetros del campo de fuerza y profundizar en la comprensión de la membrana transmembrana de las proteínas lipídicas. Estos avances han permitido la simulación de un modelo integral de la difusión de iones de litio en canales. Además, se han utilizado nanopartículas de Ge, Sn/Si como excipientes en nanobiotecnología farmacéutica. Más recientemente, se ha desarrollado óxido de silicio/germanio para su uso en sistemas de administración de fármacos. Metodología: Se realizó una investigación exhaustiva sobre Li+Na+(SiOGe), Li+K+(SiOGe), Li+Na+(SiOSn) y Li+K+(SiOSn) mediante el nivel "CAM–B3LYP–D3/6-311+G (d,p)" de la teoría DFT. La hipótesis del transporte de iones se corroboró mediante distribuciones de densidad de CDD, TDOS y ESP para nanoagrupaciones de Li+Na+(SiOGe), Li+K+(SiOGe), Li+Na+(SiOSn) y Li+K+(SiOSn). Resultados: Este transporte de iones produce un gradiente electroquímico crucial para diversas actividades celulares, como la regulación del volumen celular, la excitabilidad eléctrica y el transporte activo secundario. Las propiedades de GSK-3 como función específica para el diseño de fármacos para el trastorno bipolar surgieron de la investigación de datos, que son importantes para varios procesos centrales, como la síntesis de glucógeno y la terapia génica. Mediante el acoplamiento con 6tcu, las cantidades de Gemdock se secuenciaron como Li+K+(SiOGe) > Li+Na+(SiOGe) > Li+K+(SiOSn) > Li+Na+(SiOSn), lo que indica la inestabilidad de estos complejos por el monómero plegado de GSK3b. En otras palabras, la inestabilidad en la solución citoplasmática implica estabilidad en las estructuras de los complejos o se debe a las propiedades de los heterogrupos. Estas estructuras perfectas y precisas de los canales iónicos se han modificado en gran medida para mejorar nuestra comprensión de los detalles moleculares, la selectividad y la conducción iónica. El presente estudio pretende explorar diversos aspectos, incluyendo la descripción de la estructura atómica detallada, las propiedades moleculares y funcionales y, en consecuencia, su acción incompleta debido a alteraciones estructurales.
Introdução: O transtorno bipolar (TB) é considerado uma das doenças mais perigosas em países desenvolvidos. Apesar dos esforços científicos, o TB continua sendo uma preocupação significativa devido à sua ampla gama de efeitos colaterais. Diversos fármacos à base de sais de lítio têm sido fundamentais no tratamento de pacientes com esse transtorno. No entanto, a principal questão com os sais de lítio são seus conhecidos efeitos tóxicos, que podem variar dependendo da dose, via de administração e duração do tratamento. É importante também considerar o componente aniônico dos sais de lítio em qualquer plano de tratamento. A pesquisa de novos algoritmos para eventos raros levou a melhorias nos parâmetros de campos de força e a um aumento na compreensão da transmembrana de proteínas de membrana lipídica. Esses avanços permitiram a simulação de um modelo abrangente de difusão de íons de lítio em canais. Além disso, nanopartículas de Ge, Sn/Si têm sido utilizadas como excipientes em nanobiotecnologia farmacêutica. Mais recentemente, o óxido de silício/germânio foi desenvolvido para uso em sistemas de liberação de fármacos. Metodologia: Uma investigação abrangente sobre Li+Na+(SiOGe), Li+K+(SiOGe), Li+Na+(SiOSn) e Li+K+(SiOSn) foi realizada utilizando o nível "CAM–B3LYP–D3/6-311+G (d,p)" da teoria DFT. A hipótese do transporte iônico foi corroborada pelas distribuições de densidade de CDD, TDOS e ESP para os nanocúmulos de Li+Na+(SiOGe), Li+K+(SiOGe), Li+Na+(SiOSn) e Li+K+(SiOSn). Resultados: Esse transporte iônico produz um gradiente eletroquímico crucial para diversas atividades celulares, como a regulação do volume celular, a excitabilidade elétrica e o transporte ativo secundário. As propriedades da GSK-3, como função específica para o planejamento de fármacos para doenças bipolares, emergiram das pesquisas de dados, sendo importantes para diversos processos centrais, como a síntese de glicogênio e a terapia gênica. Através do acoplamento com 6tcu, as quantidades do Gemdock foram sequenciadas como Li+K+(SiOGe) > Li+Na+(SiOGe) > Li+K+(SiOSn) > Li+Na+(SiOSn), indicando a instabilidade desses complexos devido ao monômero dobrado da GSK3b. Em outras palavras, a instabilidade na solução citoplasmática significa estabilidade nas estruturas dos complexos ou devido às propriedades dos heterocúmulos. Essas estruturas perfeitas e precisas de canais iônicos foram amplamente modificadas para aprimorar nossa compreensão dos detalhes moleculares, da seletividade iônica e da condução. O presente estudo visa explorar vários aspectos, incluindo a descrição da estrutura em detalhes atômicos, propriedades moleculares e funcionais e, consequentemente, sua ação incompleta devido a alterações estruturais.
Referencias
1. A. Naeem, M. Aslam, Saifullah & K.H. Mühling. Lithium: Perspectives of nutritional beneficence, dietary intake, biogeochemistry, and biofortification of vegetables and mushrooms. Science of The Total Environment, 798, 149249 (2021). https://doi.org/10.1016/j.scitotenv.2021.149249
2. S. Shahriari, F. Mollaamin & M. Monajjemi. Increasing the performance of {[(1-x-y) LiCo0.3Cu0.7] (Al and Mg doped)] O2}, xLi2MnO3, yLiCoO2 composites as cathode material in lithium-ion battery: Synthesis and characterization. Micromachines, 14(2), 241 (2023). https://doi.org/10.3390/mi14020241
3. D.A. Hart. Lithium ions as modulators of complex biological processes: The conundrum of multiple targets, responsiveness and non-responsiveness, and the potential to prevent or correct dysregulation of systems during aging and in disease. Biomolecules, 14(8), 905 (2024). https://doi.org/10.3390/biom14080905
4. P. Dobosy, Á. Illés, A. Endrédi & G. Záray. Lithium concentration in tap water, bottled mineral water, and Danube River water in Hungary. Scientific Reports, 13, 12543 (2023). https://doi.org/10.1038/s41598-023-38864-6
5. V.J. De-Paula & O.V. Forlenza. Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges. Naunyn-Schmiedeberg's Archives of Pharmacology, 395, 105–113 (2022). https://doi.org/10.1007/s00210-021-02171-6
6. J. Requena-Osete, I.A. Akkouh, O. Ievglevskyi, M. Vandenberghe, D. Reis de Assis, T. Ueland, E. Kondratskaya, et al. Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids. Molecular Psychiatry, 28(7), 3033–3043 (2023). https://doi.org/10.1038/s41380-023-01944-0
7. D. Salem & R.J. Fecek. Role of microtubule actin crosslinking factor 1 (MACF1) in bipolar disorder pathophysiology and potential in lithium therapeutic mechanism. Translational Psychiatry 13(1), 221 (2023). https://doi.org/10.1038/s41398-023-02483-6
8. A.T. Amare, A. Thalamuthu, K.O. Schubert, J.M. Fullerton, M. Ahmed, S. Hartmann, et al. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder. Molecular Psychiatry, 28(12), 5251–5261 (2023). https://doi.org/10.1038/s41380-023-02149-1
9. A.M. Díaz-Zuluaga, J.I. Vélez, M. Cuartas, J. Valencia, M. Castaño, J.D. Palacio, M. Arcos-Burgos & C. López-Jaramillo. Ancestry component as a major predictor of lithium response in the treatment of bipolar disorder. Journal of Affective Disorders, 332, 203–209 (2023). https://doi.org/10.1016/j.jad.2023.03.058
10. M. Herrera-Rivero, K. Gutierrez-Fragosa, International Consortium on Lithium Genetics (ConLi+Gen), J. Kurtz & B.T. Baune. Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder. Translational Psychiatry, 14, 174 (2024). https://doi.org/10.1038/s41398-024-02865-4
11. N. Ishii, T. Terao & H. Hirakawa. The present state of lithium for the prevention of dementia related to Alzheimer’s dementia in clinical and epidemiological studies: A critical review. International Journal of Environmental Research and Public Health, 18(15), 7756 (2021). https://doi.org/10.3390/ijerph18157756
12. D.C. Bellinger. Lithium in drinking water-a novel environmental risk factor for autism spectrum disorder? JAMA Pediatrics, 177(6), 563–564 (2023). https://doi.org/10.1001/jamapediatrics.2023.0330
13. S.Y.-S. Chiou, K. Kysenius, Y. Huang, M.D. Habgood, L.M. Koehn, F. Qiu, P.J. Crouch, S. Varshney, K. Ganio, K.M. Dziegielewska & N.R. Saunders. Lithium administered to pregnant, lactating and neonatal rats: entry into developing brain. Fluids and Barriers of the CNS, 18, 57 (2021). https://doi.org/10.1186/s12987-021-00285-w
14. C. Pisanu, A. Meloni, G. Severino & A. Squassina. Genetic and epigenetic markers of lithium response. International Journal of Molecular Sciences, 23(3), 1555 (2022). https://doi.org/10.3390/ijms23031555
15. S.K. Bopp, U. Heilbronner, P. Schlattmann, P.J. Buspavanich, U.E. Lang, A. Heinz, T.G. Schulze, M. Adli, T.W. Mühleisen & R. Ricken. A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression. European Neuropsychopharmacology, 53, 114–119 (2021). https://doi.org/10.1016/j.euroneuro.2021.09.007
16. M. Zafrilla-López, M. Acosta-Díez, M. Mitjans, A. Giménez-Palomo, P.A. Saiz, C. Barrot-Feixat, et al. Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging. European Neuropsychopharmacology, 85, 23–31 (2024). https://doi.org/10.1016/j.euroneuro.2024.03.010
17. E.J. Calabrese, P. Pressman, A.W. Hayes, G. Dhawan, R. Kapoor, E. Agathokleous & V. Calabrese. Lithium and hormesis: Enhancement of adaptive responses and biological performance via hermetic mechanisms. Journal of Trace Elements in Medicine and Biology, 78, 127156 (2023). https://doi.org/10.1016/j.jtemb.2023.127156
18. C. Munteanu, M. Rotariu, M. Turnea, L.G. Tătăranu, G. Dogaru, C. Popescu, et al. Lithium biological action mechanisms after ischemic stroke. Life, 12(11), 1680 (2022). https://doi.org/10.3390/life12111680
19. A. Anand, K. Nakamura, J.M. Spielberg, J. Cha, H. Karne & B. Hu. Integrative analysis of lithium treatment associated effects on brain structure and peripheral gene expression reveals novel molecular insights into mechanism of action. Translational Psychiatry, 10, 103 (2020). https://doi.org/10.1038/s41398-020-0784-z
20. S. Rijal, S.H. Jang, S.J. Park & S.K. Han. Lithium enhances the GABAergic synaptic activities on the hypothalamic preoptic area (hPOA) neurons. International Journal of Molecular Sciences, 22(8), 3908 (2021). https://doi.org/10.3390/ijms22083908
21. S. Chen, B.R. Underwood, P.B. Jones, J.R. Lewis & R.N. Cardinal. Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study. PLoS Medicine, 19(3), e1003941 (2022). https://doi.org/10.1371/journal.pmed.1003941
22. A.B. Palmos, R.R.R. Duarte, D.M. Smeeth, E.C. Hedges, D.F. Nixon, S. Thuret & T.R. Powell. Lithium treatment and human hippocampal neurogenesis. Translational Psychiatry, 11, 555 (2021). https://doi.org/10.1038/s41398-021-01695-y
23. G. Henkelman, A. Arnaldsson & H. Jónsson. A fast and robust algorithm for Bader decomposition of charge density. Computational Materials Science, 36(3), 354–360 (2006). https://doi.org/10.1016/j.commatsci.2005.04.010
24. F. Mollaamin & M. Monajjemi. Adsorption ability of Ga5N10 nanomaterial for removing metal ions contamination from drinking water by DFT. International Journal of Quantum Chemistry, 124(2), e27348 (2024). https://doi.org/10.1002/qua.27348
25. F. Mollaamin & M. Monajjemi. Electric and magnetic evaluation of aluminum–magnesium nanoalloy decorated with germanium through heterocyclic carbenes adsorption: A density functional theory study. Russian Journal of Physical Chemistry B, 17, 658–672 (2023). https://doi.org/10.1134/s1990793123030223
26. F. Mollaamin. Competitive intracellular hydrogen-nanocarrier among aluminum, carbon, or silicon implantation: A novel technology of eco-friendly energy storage using research density functional theory. Russian Journal of Physical Chemistry B, 18, 805–820 (2024). https://doi.org/10.1134/S1990793124700131
27. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, et al. Gaussian 16, Revision C.01, Gaussian, Inc., Wallingford CT, 2016.
28. R. Dennington, T.A. Keith, A. Todd & J.M. Millam. GaussView, Version 6.06.16, Semichem Inc., Shawnee Mission, KS, 2016.
29. G.J. Moore, J.M. Bebchuk, K. Hasanat, G. Chen, N. Seraji-Bozorgzad, I.B. Wilds, M.W. Faulk, S. Koch, D.A. Glitz, L. Jolkovsky & H.K. Manji. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? Biological Psychiatry, 48, 1–8 (2000). https://doi.org/10.1016/S0006-3223(00)00252-3
30. M.L. Phillips, M.J. Travis, A. Fagiolini & D. Kupfer. Medication effects in neuroimaging studies of bipolar disorder. The American Journal of Psychiatry, 165(3), 313–320 (2008). https://doi.org/10.1176/appi.ajp.2007.07071066
31. R.B. Sassi, P. Brambilla, J.P. Hatch, M.A. Nicoletti, A.G. Mallinger, E. Frank, D.J. Kupfer, M.S. Keshavan & J.C. Soares. Reduced left anterior cingulate volumes in untreated bipolar patients. Biological Psychiatry, 56(7), 467–475 (2004). https://doi.org/10.1016/j.biopsych.2004.07.005
32. R.B. Sassi, M. Nicoletti, P. Brambilla, A.G. Mallinger, E. Frank, D.J. Kupfer, M.S. Keshavan & J.C. Soares. Increased gray matter volume in lithium-treated bipolar disorder patients. Neuroscience Letters, 329(2), 243–245 (2002). https://doi.org/10.1016/S0304-3940(02)00615-8
33. C.E. Bearden, P.M. Thompson, M. Dalwani, K.M. Hayashi, A.D. Lee, M. Nicoletti, et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biological Psychiatry, 62(1), 7–16 (2007). https://doi.org/10.1016/j.biopsych.2006.10.027
34. C.E. Bearden, P.M. Thompson, R.A. Dutton, B.N. Frey, M.A.M. Peluso, M. Nicoletti, et al. Three-dimensional mapping of hippocampal anatomy in un-medicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology, 33(6), 1229–1238 (2008). https://doi.org/10.1038/sj.npp.1301507
35. G.J. Moore, J.M. Bebchuk, I.B. Wilds, G. Chen & H.K. Manji. Lithium-induced increase in human brain grey matter. The Lancet, 356(9237), 1241–1242 (2000). https://doi.org/10.1016/s0140-6736(00)02793-8
36. P.H. Silverstone, R.H. Wu, T. O’Donnell, M. Ulrich, S.J. Asghar & C.C. Hanstock. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. International Clinical Psychopharmacology, 18(2), 73–79 (2003). https://doi.org/10.1097/00004850-200303000-00002
37. G.J. Moore, J.M. Bebchuk, J.K. Parrish, M.W. Faulk, C.L. Arfken, J. Strahl-Bevacqua & H.K. Manji. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. American Journal of Psychiatry, 156(12), 1902–1908 (1999). https://doi.org/10.1176/ajp.156.12.1902
38. R.S. Jope. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends in Pharmacological Sciences, 24(9), 441–443 (2003). https://doi.org/10.1016/s0165-6147(03)00206-2
39. F. Benedetti, A. Serretti, C. Colombo, C. Lorenzi, V. Tubazio & E. Smeraldi. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neuroscience Letters, 368(2), 123–126 (2004). https://doi.org/10.1016/j.neulet.2004.06.050
40. T.D. Gould, C.A. Zarate & H.K. Manji. Glycogen synthase kinase-3: A target for novel bipolar disorder treatments. The Journal of Clinical Psychiatry, 65(1), 10–21 (2004). URL: https://www.psychiatrist.com/jcp/glycogen-synthase-kinase-target-novel-bipolar-disorder/
41. Z. Xu, C. Qin, Y. Yu, G. Jiang & L. Zhao. First-principles study of adsorption, dissociation, and diffusion of hydrogen on α-U (110) surface. AIP Advances, 14, 055114 (2024). https://doi.org/10.1063/5.0208082
42. N.M. O’Boyle, A.L. Tenderholt & K.M. Langner. cclib: A library for package-independent computational chemistry algorithms. Journal of Computational Chemistry, 29(5), 839–845 (2008). https://doi.org/10.1002/jcc.20823
43. J.S. Murray & P. Politzer, The electrostatic potential: An overview. WIREs Computational Molecular Science, 1(2), 153–163 (2011). https://doi.org/10.1002/wcms.19
44. T. Lu & F. Chen. Multiwfn: A multifunctional wavefunction analyzer. Journal of Computational Chemistry, 33(5), 580–592 (2012). https://doi.org/10.1002/jcc.22885
45. T. Lu. A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn. The Journal of Chemical Physics, 161, 082503 (2024). https://doi.org/10.1063/5.0216272
46. F. Prati, R. Buonfiglio, G. Furlotti, C. Cavarischia, G. Mangano, R. Picollo, et al. Optimization of indazole-based GSK-3 inhibitors with mitigated hERG issue and in vivo activity in a mood disorder model. ACS Medicinal Chemistry Letters, 11(5), 825–831 (2020). https://doi.org/10.1021/acsmedchemlett.9b00633
47. L. Pinzi & G. Rastelli. Molecular docking: Shifting paradigms in drug discovery. International Journal of Molecular Sciences, 20(18), 4331 (2019). https://doi.org/10.3390/ijms20184331
48. P.H.M. Torres, A.C.R. Sodero, P. Jofily & F.P. Silva-Jr. Key topics in molecular docking for drug design. International Journal of Molecular Sciences, 20(18), 4574 (2019). https://doi.org/10.3390/ijms20184574
49. J.A. Bertrand, S. Thieffine, A. Vulpetti, C. Cristiani, B. Valsasina, S. Knapp, H.M. Kalisz & M. Flocco. Structural characterization of the GSK-3 active site using selective and non-selective ATP-mimetic inhibitors. Journal of Molecular Biology, 333(2), 393–407 (2006). https://doi.org/10.1016/j.jmb.2003.08.031
50. D.S. Patel, N. Dessalew, P. Iqbal & P.V. Bharatam. Structure-based approaches in the design of GSK-3 selective inhibitors. Current Protein & Peptide Science, 8(4), 352–364 (2007). https://doi.org/10.2174/138920307781369409
51. K. Govarthanan, R.S.M. Sundaram, A.S. Richard, S.C. Chabathula, S. Rupert, J. Sathyanesan, et al. Inhibition of GSK-3β restores differentiation potential of late-passage mesenchymal stem cells. Pharmaceuticals, 18(4), 483 (2025). https://doi.org/10.3390/ph18040483
52. Q. Lei, F. Gao, T. Liu, W. Ren, L. Chen, Y. Cao, et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow–derived mesenchymal stem cells and slow age-related degeneration. Science: Translational Medicine, 13(718), eaaz8697 (2021). https://doi.org/10.1126/scitranslmed.aaz8697
53. F. Takahashi-Yanaga. Activator or inhibitor? GSK-3 as a new drug target. Biochemical Pharmacology, 86(2), 191–199 (2013). https://doi.org/10.1016/j.bcp.2013.04.022
54. V.K. Rethineswaran, D.Y. Kim, Y.-J. Kim, W.B. Jang, S.T. Ji, L.T.H. Van, L.T.T. Giang, J.S. Ha, J. Yun, J. Jung & S.-M. Kwon. CHIR99021 augmented the function of late endothelial progenitor cells by preventing replicative senescence. International Journal of Molecular Sciences, 22(9), 4796 (2021). https://doi.org/10.3390/ijms22094796
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2026 Revista Colombiana de Ciencias Químico-Farmacéuticas

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
El Departamento de Farmacia de la Facultad de Ciencias de la Universidad Nacional de Colombia autoriza la fotocopia de artículos y textos para fines de uso académico o interno de las instituciones citando la fuente. Las ideas emitidas por los autores son responsabilidad expresa de estos y no de la revista.
Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons de Atribución 4.0 aprobada en Colombia. Consulte la normativa en: http://co.creativecommons.org/?page_id=13




